imt-2021-0013 - Supplementary Material - Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models
收藏数据链接：
官方服务：
资源简介：
<b>Supplementary Table 2. Assessment of GvHD in transplanted mice – modified chronic sclerodermatous GvHD scoring protocol.</b>
提供机构：
Future Science Group创建时间：
2021-09-08
